by Jordana Choucair | Nov 21, 2022 | Payers
Large employers are bracing for a very expensive year as a convergence of factors drive up health costs. Previously, employers have been able to shift some of the cost burden to workers through premium increases or high-deductible plans. However, experts predict that...
by Jordana Choucair | Nov 18, 2022 | D.C. News
House Speaker Nancy Pelosi will relinquish her leadership post, a move that marks the end of an era and sets up a shakeup for House Democrats. Pelosi’s announcement came one day after late midterm results projected Republicans will win control of the House....
by Jordana Choucair | Nov 18, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first drug to prevent type 1 diabetes. Tzield, from ProventionBio and Sanofi, was approved to delay the onset of stage 3 type 1 diabetes in adults and children ages 8 and up who currently have stage 2 type 1...
by Jordana Choucair | Nov 18, 2022 | Opioid/Substance Use Disorders
A study published in JAMA Network Open found that individuals with substance use disorders (SUDs) had significant annual declines in SUD-related emergency department use over five years compared with patients who received “usual care.” The study notes that...
by Jordana Choucair | Nov 18, 2022 | Payers
Centene announced it will sell its Magellan Specialty Health to administrator Evolent Health (Evolent) as part of the insurer’s ongoing efforts to jettison its non-health plan businesses. Evolent will pay at least $400 million in cash and approximately $200 million in...
Recent Comments